The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...

A new drug could manage aortic valve stenosis, slowing disease progression and reducing the need for aortic valve surgeries.

Sue Dumbauld got an alert from her Apple Watch that her heart rate was dangerously high. This inspired her to exercise ahead ...

If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to manage ...

For the first time, researchers said SGLT2 inhibitors may have some disease-modifying potential for nonsevere aortic stenosis ...

Women are often underdiagnosed and undertreated when it comes to heart disease, particularly conditions like aortic stenosis.

Aortic stenosis is fairly uncommon among young people, though not absent. In younger folks, the disease is typically caused by a congenital heart condition. As we age, calcium deposits can build up ...

WASHINGTON—The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers at Mayo ...